Year: 2025
Type: article
Abstract: Clonal Hematopoiesis (CH) involves the presence of specific blood cell clones that have acquired mutations, often linked to ageing, detectable in the blood without necessarily indicating disease. In the realm of liquid biopsy—particularly for cancer diagnosis, treatment monitoring, and risk assessment—CH offers both challenges and valuable insights.
Source: The Journal of Liquid Biopsy
Author: Veronica Aran
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,080
OpenAlex ID: W4408519529
